TegMine Therapeutics
PrivateTotal Funding Raised
$6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TegMine Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. It has raised $6M.
TegMine Therapeutics is a biotechnology company that develops antibody-based therapeutics targeting cancer-associated glycans and glycoproteins to improve precision oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TegMine Therapeutics Comparables
Compare TegMine Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tacalyx | 85% | |
| Combotope Therapeutics | 83% | |
| Valora Therapeutics Inc. | 83% |
For institutional investors. Book with your work email.
TegMine Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 83% MoM.
- Nov 9, 2025
Monthly visitors grew 2342% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
TegMine Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TegMine Therapeutics's valuation, stock price, and market status.
Is TegMine Therapeutics a public or private company?
TegMine Therapeutics is a private company.
What is the current stock price of TegMine Therapeutics?
TegMine Therapeutics is a private company, so its shares have no public market price. Caplight tracks TegMine Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TegMine Therapeutics worth (valuation)?
Valuation information for TegMine Therapeutics is not publicly available.
Can I buy TegMine Therapeutics stock?
TegMine Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TegMine Therapeutics's last funding round?
Funding round information for TegMine Therapeutics is not publicly available.
Who are the main investors in TegMine Therapeutics?
Investor information for TegMine Therapeutics is not publicly disclosed.
Will TegMine Therapeutics IPO soon?
No public IPO plans have been announced for TegMine Therapeutics.
How can I track TegMine Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in TegMine Therapeutics's shares on secondary markets.